Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 3 1

Status

Completed 6Recruiting 5Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 29OTHER_GOV 5INDUSTRY 3

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Breast 2

Conditions

Breast Neoplasms 2Rectal Neoplasms 1Lymphedema 1Liver Diseases 1Carcinoma, Hepatocellular 1

Interventions

Drug Therapy 10pembrolizumab 9Bevacizumab 9Radiotherapy 8Cyclophosphamide 8Carboplatin 8Oxaliplatin 7tislelizumab 6Surgical Procedures, Operative 6Docetaxel 6Cisplatin 6Capecitabine 6Paclitaxel 5Nivolumab 5Fluorouracil 5Control Groups 5fludarabine 4Immune Checkpoint Inhibitors 4Gemcitabine 4Endoscopic Mucosal Resection 4sintilimab 3Trastuzumab 3Pemetrexed 3Neoadjuvant Therapy 3Leucovorin 3Laparoscopy 3Irinotecan 3Injections 3Hematologic Tests 3HMPL-013 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × OTHER_GOV × Control Groups × Clear all
NCT07150624 2026-05-11

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

Anhui Provincial Hospital

Phase 4 Recruiting
96 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT06972160 2025-05-14

Intervention Project to Increase Adherence to Colorectal Cancer Screening in Barcelos/Esposende

Local Health Unit Barcelos/Esposende, Public Health Unit

Phase NA Recruiting
1,038 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06839885 2025-02-21

Effects of Hydrotherapy on Unilateral Lower Extremity Lymphedema

Gaziosmanpasa Research and Education Hospital

Phase NA Recruiting
52 enrolled

Lymphedema

NCT05063136 2024-11-04

Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer

Henan Cancer Hospital

Phase 3 Recruiting
1,979 enrolled
Breast

Breast Neoplasms

NCT06605521 2024-09-20

To Evaluate the Efficacy and Safety of Ipsilateral Supraclavicular Lymph Node Dissection for Breast Cancer Patients

Henan Cancer Hospital

Recruiting
300 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡